For the full fiscal year ended September 30, 2007, revenues in the U.S. were $3.033 billion, representing an increase of 11 percent over the prior year period. Revenues outside of the U.S. were $3.327 billion, representing an increase of 11 percent over the prior year period, and reflected an estimated 5 percent favorable impact from foreign currency translation.
Fiscal 2008 Outlook for Full Year
The Company estimates that diluted earnings per share from continuing operations for the full fiscal year 2008 will increase approximately 10 to 12 percent over diluted earnings per share from continuing operations, excluding specified items, of $3.84 for the fiscal year 2007.
Conference Call Information
A conference call regarding BD's fourth fiscal quarter and full year results and its expectations for fiscal year 2008 will be broadcast live on BD's website, http://www.bd.com/investors, at 10:00 a.m. (ET) Thursday, November 1, 2007. The conference call will be available for replay through the close of business on November 8, 2007 on BD's website, http://www.bd.com/investors, or at 1- 800-475-6701 (domestic) and 1-320-365-3844 (international), access code 889224.
This news release contains certain non-GAAP financial measures. A reconciliation of these and other measures to the comparable GAAP measures is included in this release and in the attached financial tables.
BD, a leading global medical technology company that manufactures and
sells medical devices, instrument systems and reagents, is dedicated to
improving people's health throughout the world. BD is focused on improving
drug therapy, enhancing the quality and speed of diagnosing infectious
diseases, and advancing research and d
|SOURCE BD (Becton Dickinson and Company)|
Copyright©2007 PR Newswire.
All rights reserved